Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ropivacaine for postoperative pain after laparoscopic colorectal resection
ACTRN12616000359437Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Hunter New England Local Health District. Primary endpoint: Difference in pre-operative and post-operative De Morton Mobility Index score. Started Jul 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12616000359437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000359437.